Core Viewpoint - Despite strong performance in the zero-sugar segment and slightly better-than-expected Q4 results, Coca-Cola's 2026 growth guidance appears weak, disappointing the market [1][3]. Financial Performance - Q4 revenue reached $11.82 billion, a 2% year-over-year increase, with organic revenue growth of 5% [1]. - Comparable EPS was $0.58, up 6% year-over-year, slightly exceeding analyst expectations [1]. - North America operating profit fell 65% year-over-year due to a $960 million non-cash impairment charge related to the BodyArmor brand acquisition [8]. Sales and Pricing - Global unit case volume grew by 1%, with price/mix growth of 1%, indicating maintained pricing power but at a reduced rate compared to previous years [9]. - Coca-Cola Zero Sugar was a standout product, with Q4 sales surging 13% and a 14% increase for the year [9]. - Traditional full-sugar soda sales faced pressure due to declining consumer demand, while Diet Coke remained flat for the year [9]. Future Outlook - Coca-Cola expects organic sales growth for 2026 to be between 4% and 5%, below Wall Street's average expectation of 5.01% [3][6]. - The company anticipates comparable EPS growth of 7% to 8% from a base of $3.00 in 2025, indicating a shift from the previous inflation-driven growth to a more moderate growth environment [6]. Market and Policy Challenges - The company faces increasing macroeconomic pressures, including health concerns regarding sugary drinks and state-level restrictions on soft drink purchases using food assistance benefits [5][11]. - Coca-Cola is diversifying its product portfolio to address these challenges, promoting healthier options and leveraging sports events for marketing [11].
BodyArmor减值拖累,可口可乐Q4 GAAP营业利润同比下滑32%,全年指引不及预期|财报见闻